Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ayurvedic cannabis preparation (THC:CBD 1:1)
- Development stage
- Phase 3
- Lead developer
- Tata Memorial Centre
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This Ayurvedic cannabis preparation is an oral formulation containing a 1:1 ratio of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), with studied doses including 5 mg or 2.5 mg of each component. Developed by Tata Memorial Hospital, the drug is being investigated in a Phase 1 clinical trial for use in the peri-operative period for patients with breast cancer and oral cavity squamous cell carcinoma. The study aims to evaluate the safety, pharmacokinetic profile, and transcriptomic effects of the preparation, specifically looking at its impact on gene expression profiling in tumor tissues and its potential to ameliorate surgical stress responses and modulate cancer-related pathways through the endocannabinoid system.
- Other names
- Cannabis capsulesAyurvedic oral cannabis preparationTHC:CBD 1:1 preparation
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)CNR2 (Cannabinoid receptor type 2)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on Ayurvedic cannabis preparation (THC:CBD 1:1).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ayurvedic cannabis preparation (THC:CBD 1:1).